BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nascimento-Dos-Santos G, Teixeira-Pinheiro LC, da Silva-Júnior AJ, Carvalho LRP, Mesentier-Louro LA, Hauswirth WW, Mendez-Otero R, Santiago MF, Petrs-Silva H. Effects of a combinatorial treatment with gene and cell therapy on retinal ganglion cell survival and axonal outgrowth after optic nerve injury. Gene Ther 2020;27:27-39. [PMID: 31243393 DOI: 10.1038/s41434-019-0089-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Soares MBP, Gonçalves RGJ, Vasques JF, da Silva-junior AJ, Gubert F, Santos GC, de Santana TA, Almeida Sampaio GL, Silva DN, Dominici M, Mendez-otero R. Current Status of Mesenchymal Stem/Stromal Cells for Treatment of Neurological Diseases. Front Mol Neurosci 2022;15:883378. [DOI: 10.3389/fnmol.2022.883378] [Reference Citation Analysis]
2 da Silva-Junior AJ, Mesentier-Louro LA, Nascimento-Dos-Santos G, Teixeira-Pinheiro LC, Vasques JF, Chimeli-Ormonde L, Bodart-Santos V, de Carvalho LRP, Santiago MF, Mendez-Otero R. Human mesenchymal stem cell therapy promotes retinal ganglion cell survival and target reconnection after optic nerve crush in adult rats. Stem Cell Res Ther 2021;12:69. [PMID: 33468246 DOI: 10.1186/s13287-020-02130-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Coco-Martin RM, Pastor-Idoate S, Pastor JC. Cell Replacement Therapy for Retinal and Optic Nerve Diseases: Cell Sources, Clinical Trials and Challenges. Pharmaceutics 2021;13:865. [PMID: 34208272 DOI: 10.3390/pharmaceutics13060865] [Reference Citation Analysis]
4 Chen X, Xu M, Zhang X, Barnstable CJ, Li X, Tombran-Tink J. Deletion of the Pedf gene leads to inflammation, photoreceptor loss and vascular disturbances in the retina. Exp Eye Res 2022;222:109171. [PMID: 35809620 DOI: 10.1016/j.exer.2022.109171] [Reference Citation Analysis]
5 Rebustini IT, Bernardo-Colón A, Nalvarte AI, Becerra SP. Delivery Systems of Retinoprotective Proteins in the Retina. Int J Mol Sci 2021;22:5344. [PMID: 34069505 DOI: 10.3390/ijms22105344] [Reference Citation Analysis]
6 Rhee J, Shih KC. Use of Gene Therapy in Retinal Ganglion Cell Neuroprotection: Current Concepts and Future Directions. Biomolecules 2021;11:581. [PMID: 33920974 DOI: 10.3390/biom11040581] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]